Paxlovid: A Lifesaver for COVID-19 Patients, but not everyone gets it
Study reveals Low Usage Rates of COVID-19 Antiviral Treatments in Nursing Homes: A Call for Action
Topline:
Recent research published in JAMA reveals a concerning underutilization of Paxlovid, a key antiviral medication for COVID-19, particularly among nursing home residents. Despite its proven effectiveness in reducing hospitalizations and deaths, only a fraction of eligible patients are receiving this potentially lifesaving treatment.
Study Details:
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.